404
Participants
Start Date
June 30, 2010
Primary Completion Date
July 31, 2013
Glyco-conjugate Neisseria meningitidis serogroup C (MenC) vaccine
"In order to ensure proper intramuscular injection of the study vaccines, a 23G (0.5mm in diameter) needle of at least 1 inch (2.54 cm) length will be used. All vaccines will be administered intramuscularly.~Then MenC vaccine will administered either once (at 3 months) or twice (at 3 and 4 months) depending on treatment group to either the thigh, deltoid or a combination of the two."
Routine schedule immunisations except monovalent MenC vaccine
Routine schedule immunisations will be given according to NHS guidelines.
Oxford Vaccine Group, Oxford
Collaborators (1)
Oxford University Hospitals NHS Trust
OTHER
GlaxoSmithKline
INDUSTRY
University of Oxford
OTHER